This Study Aims to Find and Test a Safe Dose of BI 905677 in Patients With Different Types of Cancer (Solid Tumours)

NCT03604445 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
37
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor decision

Conditions

Interventions

Sponsor

Boehringer Ingelheim